Livewire Ergogenics Inc LVVV
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LVVV is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.01
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $1.91 Mil
- Volume/Avg
- 874,709 / 924,316
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Livewire Ergogenics Inc is operating in the cannabis-related health and wellness industry. It focused on acquiring special-purpose real estate properties conducive to the production of handcrafted and organically grown cannabis products for medical and recreational adult use in California. The company is based in Anaheim, California, and operates its main facility in Paso Robles.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
Valuation
Metric
|
LVVV
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
LVVV
Financial Strength
Metric
|
LVVV
|
---|---|
Quick Ratio | — |
Current Ratio | 0.16 |
Interest Coverage | −23.78 |
Quick Ratio
LVVV
Profitability
Metric
|
LVVV
|
---|---|
Return on Assets (Normalized) | −236.01% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
LVVV
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Kdgcgrybh | Lsrfhgd | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Swcvlszxm | Vxy | $68.9 Bil | |
HLN
| Haleon PLC ADR | Hgdblqz | Qyf | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Nnvqypjb | Hjqf | $14.8 Bil | |
VTRS
| Viatris Inc | Brkysydt | Qhhd | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cqptvdcpd | Lqp | $11.9 Bil | |
CTLT
| Catalent Inc | Ywjjqyyzn | Rjrrmm | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Dcjxpjvwb | Fgr | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Mzvvltjf | Trt | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ybmqrxhx | Wltxy | $3.5 Bil |